Skip to content

npj Mental Health Research

ISSN 2731-4251

24 papers in the library · 82 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Matters arising: Methodological concerns and interpretative limitations of assessing subjective effects of ketamine

npj Mental Health Research September 22, 2026 Ramūnas Janavičius

The letter addresses critical issues in the methodology and conclusions of the meta-analysis, including inconsistencies in study design, methodological flaws in comparing correlation coefficients, and discrepancies in reported results and their interpretation. It contributes significantly to the ongoing discussion on psychedelic-assisted therapies and highlights the need for more standardized...

Reply to ‘Methodological concerns and interpretative limitations of assessing subjective effects of ketamine’

npj Mental Health Research September 22, 2026 Jack D. C. Dahan, David Dadiomov, Tijmen Bostoen et al.

This response addresses methodological concerns raised regarding our meta-analysis of subjective effects and therapeutic outcomes following ketamine and psilocybin treatment. We discuss the potential influence of psychotherapy and differences in subjective-effect questionnaires across studies, acknowledging these as important limitations. We argue that these factors may partly explain observed...

High ventilation breathwork as a non-pharmacological model for inducing psychedelic-like states: expert evaluations of therapeutic potential and risk

npj Mental Health Research September 17, 2026 U. Lueken, Isabel Dziobek, Martha N. Havenith et al.

High ventilation breathwork (HVB) can induce altered states of consciousness with phenomenological similarities to those reported following administration of serotonergic psychedelics such as lysergic acid diethylamide (LSD), psilocybin or ayahuasca. Non-pharmacological methods capable of reliably eliciting such states may provide scalable models for investigating therapeutic mechanisms...

Exploratory safety, tolerability, and feasibility of psilocybin-assisted psychotherapy for adults with co-occurring treatment-resistant depression and cluster B personality disorders

npj Mental Health Research September 16, 2026 Orly Lipsitz, Ryan M Brudner, Zoe Doyle et al.

Cluster B personality disorders (PDs) are highly comorbid with depression and are associated with attenuated antidepressant response. No clinical trials to date have reported on psilocybin-assisted psychotherapy (PAP) in comorbid treatment-resistant depression (TRD) and PDs. This is the first clinical trial to describe a subgroup of ten participants with a comorbid PD ( n = 9 cluster B; n = 1...

Prior ayahuasca experience is associated with improved mental health: observational data from ritualistic settings

npj Mental Health Research September 10, 2026 Lucas Cruz, Marcio S. C. Longo, Rafael S. Rodrigues et al.

Abstract This observational survey study investigated the relationship between prior ayahuasca experience and mental health and mindset outcomes. Participants planning to attend an ayahuasca ceremony completed a survey before their upcoming ayahuasca use. Measures included substance use, depression, anxiety, stress, spiritual well-being, aberrant salience, and metaphysical beliefs. Participants...

Well-being as a primary endpoint in clinical trials: a call for consensus

npj Mental Health Research August 6, 2026 Elliot Marseille, Hannes Kettner, Tyrone J. Sgambati et al.

Abstract Psychiatric trials typically define success as symptom reduction, yet patients prioritize meaning, vitality, and functioning. This imbalance undervalues experiential benefits, distorting clinical, policy, and FDA decisions. Psychedelic trials illustrate this, where robust well-being gains sometimes accompany modest symptom effects. We argue well-being should be elevated to co-primary...

Childhood trauma and psychological outcomes following psychedelic use: a scoping review

npj Mental Health Research July 30, 2026 Lorraine Li, Paige Seath, Nadav Liam Modlin et al.

Abstract Research examining psychological outcomes following psychedelic use has grown substantially, yet the role of childhood trauma in shaping these responses remains insufficiently understood. This scoping review mapped the literature examining childhood trauma in relation to post-psychedelic psychological outcomes. Thirty-four sources met inclusion criteria and investigated substances...

A scoping review: ketamine or esketamine when used to assist psychotherapy or in combination with psychotherapy for the management of depression in adults

npj Mental Health Research July 27, 2026 Jennifer Swainson, P. Grewal, S. Polard et al.

This scoping review maps literature for use of ketamine or esketamine with psychotherapy for depression or depressive symptoms. Forty-seven studies were identified including 4/47 (9%) randomized controlled trials, 4/47 (9%) open label trials, 27/47 (57%) observational or retrospective studies, and 12/47 (26%) individual case reports. Studies were categorized as Ketamine/Esketamine Combined with...

Personality changes following first-time psychedelic use in college students in Germany

npj Mental Health Research July 10, 2026 Constantin Volkmann, Michael Seitz, Ricarda Evens et al.

Psychedelics may influence personality traits, but longitudinal evidence on first-time use outside clinical settings remains limited. We followed 102 first-time psychedelic users and 1066 never-users over one year among Berlin university students. Personality was assessed with the Big Five Inventory at baseline and follow-up. Linear mixed-effects models showed small relative increases in...

Mindfulness-based interventions and cognitive behavioral therapy for depression, anxiety, and stress in adults with chronic conditions: a stratified subgroup meta-analysis.

npj Mental Health Research May 30, 2026 Kenni Wojujutari Ajele, Botho Nanvula Ramonkga, Matthew O Olasupo et al.

Anxiety, depression, and stress are common in individuals with diabetes and cancer and are associated with poor self-management and well-being. Cognitive behavioral therapy (CBT) and mindfulness-based interventions (MBIs) are widely used in nonpharmacological treatments, but their comparative effectiveness remains unclear. We conducted a stratified subgroup meta-analysis to indirectly compare...

A systematic review on mindfulness-based immersive interventions in depressive disorders

npj Mental Health Research April 2, 2026 Peng Tan, Yuqi Wu, Xinrong Chen et al. 3 citations

Depressive disorders are characterized by persistent negative affect, rumination, and impaired emotion regulation, contributing substantially to global disease burden. As recurrent rumination and negative attentional biases are central cognitive mechanisms of depression, interventions targeting these processes have gained increasing attention. Mindfulness-based interventions (MBIs) effectively...

DOI: 10.1038/s44184-026-00205-6 (opens in new tab) Full text (opens in new tab) Anxiety Psychological intervention Rumination Neurocognitive +9

Effects of mindfulness-based interventions on perceived stress among non-clinical adults: a systematic review and meta-analysis.

npj Mental Health Research February 3, 2026 Anisha Rajan, Mahendra Kumar, Pranav Raj P 1 citation

Mindfulness-based interventions (MBIs) are recognised as effective psychosocial strategies for managing stress. We conducted a systematic review and meta-analysis of studies published up to August 2025 across the Web of Science, PubMed, Scopus, PsycINFO, EBSCO and Google Scholar following the PRISMA guidelines. Seventeen randomised controlled trials (n = 1,641) met the inclusion criteria....

Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders.

npj Mental Health Research January 31, 2026 Clayton Olash, Derrick Matthew Buchanan, Randi Brown et al. 1 citation

Magnesium-ibogaine, a formulation combining ibogaine with pre- and post-treatment magnesium, was recently found to yield rapid clinical improvements in U.S. Special Operations veterans with TBI and PTSD. Yet, its therapeutic phenomenology during such healing is unknown. We analyzed post-session narratives from 30 male veterans who, after a single open-label magnesium-ibogaine treatment,...

Learning from boundlessness: epistemic shifts towards a holistic worldview following psychedelic experiences

npj Mental Health Research January 29, 2026 Eirini K. Argyri, Flora Fraser, Stefan Schilling et al.

Psychedelic substances are increasingly recognized for their potential to catalyse transformative shifts in worldviews. Central to these transformations may be the integration of self-transcendent states. This mixed-methods study explored transformative psychedelic experiences, focussing on subsequent epistemic shifts. Ninety participants completed the Awe Experience Scale (AWE-S), and the...

DOI: 10.1038/s44184-026-00186-6 (opens in new tab) Full text (opens in new tab) Transformative learning Openness to experience Thematic analysis Compassion +8

Unlocking deep relaxation: the power of rhythmic breathing on brain rhythms.

npj Mental Health Research August 23, 2025 Vaibhav Tripathi, Lakshmi Bhaskar, Chhaya Kharya et al.

The pandemic has exacerbated mental health issues across the world. The limited availability of mental health professionals is preventing many from seeking help, which highlights the need for easily available mental health care routines like yoga, breathing, and meditation. A breath-based meditation technique known as Sudarshan Kriya Yoga (SKY) harnesses the power of breath to induce deep...

Functional connectivity-related changes underlying mindfulness meditation for internet gaming disorder: a randomized clinical trial.

npj Mental Health Research July 31, 2025 Xuefeng Xu, Haosen Ni, Huabin Wang et al.

Internet gaming disorder (IGD) is recognized as a mental health issue. Traditional interventions have limitations, but mindfulness meditation (MM) shows promise due to its flexibility and social acceptance. Study 1, fMRI data from 61 IGD patients and 60 healthy controls (HCs) were compared to assess functional connectivity (FC). Study 2- a randomized clinical trial, 80 IGD patients underwent...

Impaired mnemonic pattern separation associated with PTSD symptoms paradoxically improves with regular cannabis use

npj Mental Health Research April 24, 2025 Jacob Ross, Bruna Cuccurazzu, Dylan Delmar et al. 1 citation

Posttraumatic stress disorder (PTSD) is associated with poor hippocampal function and disrupted pattern recognition. Cannabis use is highly prevalent in individuals with PTSD, yet the impact on these cognitive functions is poorly understood. Participants (n = 111) with a range of PTSD symptoms with and without regular cannabis use completed the mnemonic similarity task. We hypothesized that...

A qualitative analysis of the psychedelic mushroom come-up and come-down.

npj Mental Health Research February 7, 2025 Ari Brouwer, Joshua K Brown, Earth Erowid et al. 5 citations

Psychedelic therapy has the potential to become a revolutionary and transdiagnostic mental health treatment, yielding enduring benefits that are often attributed to the experiences that coincide with peak psychedelic effects. However, there may be an underrecognized temporal structure to this process that helps explain why psychedelic and related altered states of consciousness can have an...

DOI: 10.1038/s44184-024-00095-6 (opens in new tab) Full text (opens in new tab) Stress relief Psychedelics Mental health Altered states +1

Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.

npj Mental Health Research October 6, 2024 Jack D. C. Dahan, David Dadiomov, Tijmen Bostoen et al. 13 citations

There is some evidence that the subjective effects of ketamine and other psychedelics like psilocybin are crucial for their therapeutic outcomes, such as treatment of depression or substance use disorder (SUD). We performed a meta-analysis and systematic review on the correlation of subjective symptoms and dissociation versus ketamine-induced therapeutic outcomes in patients with depression or...

DOI: 10.1038/s44184-024-00091-w (opens in new tab) Full text (opens in new tab) Psychedelic therapy Therapeutic efficacy Mental health treatment Ketamine research +1

A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials.

npj Mental Health Research July 2, 2024 Ronit Kishon, Nadav Liam Modlin, Yael M. Cycowicz et al. 22 citations

Pre-prohibition psychedelic research with complex psychiatric patients generated a wealth of treatment methodologies and practices, providing invaluable clinical insights pertaining to the medical administration of psychedelics in various mental health diagnoses. Building upon these early studies, which lack the rigor and research tools available today, contemporary psychedelic research has...

DOI: 10.1038/s44184-024-00068-9 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Mental health treatment Clinical research Alternative medicine +1

Disability rights and experiential use of psychedelics in clinical research and practice.

npj Mental Health Research July 2, 2024 Maryam Golafshani, Daniel Z. Buchman, Muhammad Ishrat Husain 3 citations

Given the renewed interest in the use of psychedelics for the treatment of mental and substance use disorders in recent decades, there has also been renewed discussion and debate about whether it is necessary or beneficial for those who study and deliver psychedelic-assisted psychotherapy (PAP) to have had personal experience of using psychedelics. This paper provides a brief history of this...

The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects.

npj Mental Health Research February 20, 2024 Kush V. Bhatt, Cory R. Weissman 29 citations

Psilocybin is a serotonergic psychedelic shown to have enduring antidepressant effects. Currently, the mechanism for its enduring effects is not well understood. Empathy and prosocial behavior may be important for understanding the therapeutic benefit of psilocybin. In this article we review the effect of psilocybin on empathy and prosocial behavior. Moreover, we propose that psilocybin may...

DOI: 10.1038/s44184-023-00053-8 (opens in new tab) Full text (opens in new tab) Psychedelics Mental health Depression treatment Social cognition

Managing expectations with psychedelic microdosing

npj Mental Health Research November 8, 2023 Omer A. Syed, Benjamin Tsang 4 citations

The recent years have seen an unprecedented surge of psychedelic research. Studies with psilocybin (colloquially known as magic mushrooms), in particular, have shown promise in ameliorating symptoms of treatment-refractory depression, anxiety, and substance use disorder, among others 1 , 2 . Microdosing, the practice of regularly taking roughly a tenth of full psychedelic doses, is becoming...

DOI: 10.1038/s44184-023-00044-9 (opens in new tab) Full text (opens in new tab) Recreational use Mental health Applied psychology Psychotherapist

Examining Equity in Access and Utilization of a Freely Available Meditation App.

npj Mental Health Research April 18, 2023 Zishan Jiwani, Raquel G Tatar, Cortland J. Dahl et al.

Digital interventions have the potential to alleviate mental health disparities for marginalized and minoritized communities. The current study examined whether disparities in access and utilization of meditation in the United States (US) were reduced for a freely available meditation app. We analyzed demographic and usage data from US-based users of the Healthy Minds Program (HMP; N = 66,482)...

DOI: 10.1038/s44184-023-00025-y (opens in new tab) Full text (opens in new tab) Access to care Health disparities Digital technology Smartphone apps +1